title: Dopaminergic dysfunction in schizophrenia: salience attribution revisited.
abstract: A dysregulation of the mesolimbic dopamine system in schizophrenia patients may lead to aberrant attribution of incentive salience and contribute to the emergence of psychopathological symptoms like delusions. The dopaminergic signal has been conceptualized to represent a prediction error that indicates the difference between received and predicted reward. The incentive salience hypothesis states that dopamine mediates the attribution of "incentive salience" to conditioned cues that predict reward. This hypothesis was initially applied in the context of drug addiction and then transferred to schizophrenic psychosis. It was hypothesized that increased firing (chaotic or stress associated) of dopaminergic neurons in the striatum of schizophrenia patients attributes incentive salience to otherwise irrelevant stimuli. Here, we review recent neuroimaging studies directly addressing this hypothesis. They suggest that neuronal functions associated with dopaminergic signaling, such as the attribution of salience to reward-predicting stimuli and the computation of prediction errors, are indeed altered in schizophrenia patients and that this impairment appears to contribute to delusion formation.
authors.affiliation: Department of Psychiatry, Charité-Universitätsmedizin Berlin, Charité Campus Mitte, 10117 Berlin, Germany. andreas.heinz@charite.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Heinz
authors.forename: Florian
authors.initials: F
authors.lastname: Schlagenhauf
mesh_terms: D000818:Animals; D003213:Conditioning, Psychological / Q000502:physiology; D003702:Delusions / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009042:Motivation / Q000502:physiology*; D009415:Nerve Net / Q000503:physiopathology; D009474:Neurons / Q000502:physiology; D010101:Oxygen Consumption / Q000502:physiology; D018187:Personal Construct Theory; D049268:Positron-Emission Tomography; D017397:Prefrontal Cortex / Q000503:physiopathology; D017447:Receptors, Dopamine D1 / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000502:physiology*; D012016:Reference Values; D012201:Reward; D012559:Schizophrenia / Q000175:diagnosis / Q000503:physiopathology*; D012565:Schizophrenic Psychology; D015398:Signal Transduction; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology
chemical_list: D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D004298:Dopamine
references.citation: Scand J Psychol. 2003 Jul;44(3):289-92
references.pmid: 12914593
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2569-74
references.pmid: 9122236
references.citation: Schizophr Res. 1998 May 4;31(1):19-26
references.pmid: 9633833
references.citation: Arch Gen Psychiatry. 1987 Jul;44(7):671-2
references.pmid: 2955770
references.citation: Am J Psychiatry. 2003 Jan;160(1):13-23
references.pmid: 12505794
references.citation: J Neurosci. 1997 Nov 1;17(21):8491-7
references.pmid: 9334421
references.citation: Am J Psychiatry. 2006 Nov;163(11):1969-77
references.pmid: 17074949
references.citation: Eur Psychiatry. 2002 Mar;17(1):9-16
references.pmid: 11918987
references.citation: J Neurosci. 2007 Jul 25;27(30):8080-7
references.pmid: 17652599
references.citation: Schizophr Bull. 2007 Sep;33(5):1071-81
references.pmid: 17630406
references.citation: J Neurosci. 2008 Jun 4;28(23):5976-82
references.pmid: 18524902
references.citation: Physiol Behav. 2002 Dec;77(4-5):513-7
references.pmid: 12526992
references.citation: Biol Psychiatry. 2000 Oct 1;48(7):627-40
references.pmid: 11032974
references.citation: J Cogn Neurosci. 2005 Oct;17(10):1497-508
references.pmid: 16269092
references.citation: Synapse. 1998 May;29(1):80-3
references.pmid: 9552177
references.citation: J Neurosci. 2001 May 15;21(10):3628-38
references.pmid: 11331392
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):4-26
references.pmid: 19812543
references.citation: Med Hypotheses. 1976 Sep-Oct;2(5):203-11
references.pmid: 9558
references.citation: Int Rev Neurobiol. 2007;78:1-39
references.pmid: 17349856
references.citation: Mol Psychiatry. 2008 Mar;13(3):239, 267-76
references.pmid: 17684497
references.citation: Drug Alcohol Depend. 1995 May;38(2):95-137
references.pmid: 7671769
references.citation: Science. 1986 Dec 19;234(4783):1558-63
references.pmid: 2878495
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):301-6
references.pmid: 11134516
references.citation: Nat Neurosci. 2008 Dec;11(12):1381-2
references.pmid: 18978778
references.citation: Curr Opin Neurobiol. 2004 Dec;14(6):769-76
references.pmid: 15582382
references.citation: Ann N Y Acad Sci. 2007 May;1104:35-53
references.pmid: 17416921
references.citation: J Neurosci. 2006 Aug 9;26(32):8368-76
references.pmid: 16899732
references.citation: Neuroimage. 2001 Nov;14(5):1159-67
references.pmid: 11697947
references.citation: Psychopharmacology (Berl). 2009 Sep;206(1):121-32
references.pmid: 19521678
references.citation: Eur Neuropsychopharmacol. 2008 Aug;18(8):589-99
references.pmid: 18554874
references.citation: J Neurosci. 2002 May 1;22(9):3708-19
references.pmid: 11978847
references.citation: J Neurochem. 1989 May;52(5):1655-8
references.pmid: 2709017
references.citation: Biol Psychiatry. 2009 Jun 15;65(12):1032-9
references.pmid: 19195646
references.citation: J Cogn Neurosci. 2009 Jul;21(7):1332-45
references.pmid: 18752410
references.citation: Neuron. 2004 Jul 22;43(2):261-9
references.pmid: 15260961
references.citation: Nat Neurosci. 2002 Mar;5(3):267-71
references.pmid: 11865311
references.citation: J Comp Neurol. 2002 Sep 2;450(4):345-65
references.pmid: 12209848
references.citation: Am J Psychiatry. 2003 Dec;160(12):2209-15
references.pmid: 14638592
references.citation: Nat Neurosci. 2002 Feb;5(2):169-74
references.pmid: 11802171
references.citation: Nature. 2007 Feb 8;445(7128):643-7
references.pmid: 17287809
references.citation: Psychopharmacology (Berl). 2008 Mar;196(4):673-84
references.pmid: 18097655
references.citation: Eur J Neurosci. 2006 Jul;24(1):305-13
references.pmid: 16882026
references.citation: J Neurosci. 2000 Mar 15;20(6):2369-82
references.pmid: 10704511
references.citation: Neuropsychopharmacology. 2008 Feb;33(3):473-9
references.pmid: 17473838
references.citation: Neuroscience. 2002;110(2):257-75
references.pmid: 11958868
references.citation: Lancet. 1995 Oct 28;346(8983):1130-1
references.pmid: 7475604
references.citation: J Neurosci. 2001 Aug 15;21(16):RC159
references.pmid: 11459880
references.citation: J Neurosci. 1993 Mar;13(3):900-13
references.pmid: 8441015
references.citation: Neural Netw. 2002 Jun-Jul;15(4-6):561-72
references.pmid: 12371512
references.citation: Neuropsychopharmacology. 1988 Sep;1(3):179-86
references.pmid: 3075131
references.citation: Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S152-7
references.pmid: 14677072
references.citation: Curr Opin Neurobiol. 1996 Apr;6(2):228-36
references.pmid: 8725965
references.citation: J Comp Neurol. 1995 Mar 27;354(1):127-49
references.pmid: 7542290
references.citation: Neurosci Biobehav Rev. 1989 Summer-Fall;13(2-3):155-62
references.pmid: 2682402
references.citation: Synapse. 1999 May;32(2):71-9
references.pmid: 10231127
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8104-9
references.pmid: 10884434
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1147-58
references.pmid: 18202844
references.citation: Nervenarzt. 1999 May;70(5):399-407
references.pmid: 10407835
references.citation: Neuropsychopharmacology. 2003 Apr;28(4):787-94
references.pmid: 12655326
references.citation: Neuroimage. 2006 Jan 15;29(2):409-16
references.pmid: 16139525
references.citation: Psychopharmacology (Berl). 2006 Aug;187(2):222-8
references.pmid: 16721614
references.citation: Hum Brain Mapp. 2005 May;25(1):60-9
references.pmid: 15846819
references.citation: Psychopharmacology (Berl). 2006 Sep;187(4):486-97
references.pmid: 16823591
references.citation: Science. 2008 Aug 8;321(5890):848-51
references.pmid: 18687967
references.citation: Neuroreport. 2001 Dec 4;12(17):3683-7
references.pmid: 11726774
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Science. 1997 Mar 14;275(5306):1593-9
references.pmid: 9054347
references.citation: J Individ Psychol. 1974 May;30(1):98-113
references.pmid: 4857199
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9235-40
references.pmid: 8799184
references.citation: Schizophr Bull. 2009 Jul;35(4):668-74
references.pmid: 19487337
references.citation: Brain. 2007 Sep;130(Pt 9):2387-400
references.pmid: 17690132
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):813-22
references.pmid: 17279377